This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Chapter 13: Sick day management in children and adolescents with diabetes
View this email in your browser
,
Dear Members,
Dear Friends
 
Understanding sick day management for young persons with insulin treated diabetes is important, as children and adolescents may experience multiple acute illnesses annually, placing them at risk for diabetic ketoacidosis (DKA). Thus, it Is extremely important to be familiar with the ISPAD Clinical Guidelinses about the Sick day management. It remains important to frequently monitor glucose and ketones levels during any intercurrent illness and to provide supplemental insulin doses every 2-4 hours along with maintaining hydration status. It is very important – never to stop delivering insulin completely!

Provision of sick day education to patients and family members along with availability of 24 hour, 7 day a week access to expert health care team advice can successfully manage sick days and prevent progression to DKA in young persons with insulin-treated diabetes. Modern diabetes treatment advances can facilitate sick day management; these advancements include blood ketone monitoring in place of urine ketone checks and use of continuous glucose monitoring (CGM) devices that provide frequent glucose data along with trend arrows that can assist with fine-tuning insulin dose adjustments.
Lastly, there are special clinical situations that place young persons with diabetes at high risk for ketogenesis and progression to DKA, including youth with disordered eating behaviors, use of SGLT1/2 inhibitors, and low carbohydrate diets. In these circumstances, frequent glucose and ketone monitoring along timely implementation of sick day management can prevent progression to DKA.
To learn more check the lecture about the Sick day management in type 1 diabetes, challenges in the developed world by Frances Mouat here.


The Conference Resource Platform has been made possible thanks to an independent educational sponsorship from
,
If you have any questions, please contact:

ISPAD Conference Secretariat
K.I.T. Group GmbH
Association & Conference Management
Tel.: +49 30 24 60 3-270
Fax: +49 30 24 60 3-200
 
,
Legal Notice
ISPAD Executive Office
c/o K.I.T. Group GmbH
Association & Conference Management

© 2019 International Society for Pediatric and Adolescent Diabetes (ISPAD)

secretariat@ispad.org
www.ispad.org

Secretariat:
c/o K.I.T. Group GmbH
Kurfürstendamm 71
10709 Berlin, Germany
Tel.: +49 30 24603 349
Phone: +49 (0)30 24603-210
Fax: +49 (0)30 24603-200
Email: secretariat@ispad.org
www.kit-group.org
Local court: Amtsgericht Berlin, HRB 114 340 B
Representatives: Willy E. Kausch, Jocelyne Mülli and Merryn Scholz



Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.



 

Contact Us

ISPAD Executive Office
c/o K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin, Germany










Join ISPAD

Click the link below to join the Society!


Join Today!










Phone: +49 (0)30 24603-210
Fax: +49 (0)30 24603-200
Email: secretariat@ispad.or
g










Privacy Policy
Terms of Service
Legal Notice    

Disclaimer



































 © 2020 International Society for Pediatric and Adolescent Diabetes (ISPAD)






Association Management Software Powered by YourMembership  ::  Legal